According to Cao et al., LBX2-AS1 is considered to be an oncogenic lncRNA in ovarian cancer, and targeted knockdown of LBX2-AS1 significantly reduces the ability of ovarian cancer cells to grow and invade (34). Here, LBX2 is linked to ovarian cancer.